He, M., Souza, E., Matvekas, A., Crass, R. L., & Pai, M. P. (2021). Alteration in Acute Kidney Injury Potential with the Combination of Vancomycin and Imipenem-Cilastatin/Relebactam or Piperacillin/Tazobactam in a Preclinical Model. Antimicrob Agents Chemother.

He, Miao, Ernane Souza, Aleksas Matvekas, Ryan L. Crass, ja Manjunath P. Pai. "Alteration in Acute Kidney Injury Potential With the Combination of Vancomycin and Imipenem-Cilastatin/Relebactam or Piperacillin/Tazobactam in a Preclinical Model." Antimicrob Agents Chemother 2021.

He, Miao, et al. "Alteration in Acute Kidney Injury Potential With the Combination of Vancomycin and Imipenem-Cilastatin/Relebactam or Piperacillin/Tazobactam in a Preclinical Model." Antimicrob Agents Chemother 2021.